
---
title: '狂犬病疫苗仅肌肉注射一针的免疫效果'
categories: 
 - 新媒体
 - 科学网
 - 博客
headimg: 'https://picsum.photos/400/300?random=6084'
author: 科学网
comments: false
date: Tue, 27 Apr 2021 08:26:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=6084'
---

<div>   
<h2 style="margin: 15px 0px 23px; text-indent: 56px; padding: 0px; background: rgb(255, 255, 255); line-height: 2em;"><span style="font-family: KaiTi;color: #0070C0;letter-spacing: 0;font-size: 24px">澳大利亚国立大学（</span><span style="font-family: Helvetica;color: #2A2A2A;letter-spacing: 0;font-size: 21px">Australian National University, Canberra</span><span style="font-family: KaiTi;color: #0070C0;letter-spacing: 0;font-size: 24px"><span style="font-family:KaiTi">）的研究人员于</span><span style="font-family:KaiTi">4月10日在专业杂志《</span></span><em><span style="font-family: KaiTi;letter-spacing: 0;font-size: 24px">Journal of Travel Medicine</span></em><span style="font-family: KaiTi;letter-spacing: 0;font-size: 24px">（旅行医学杂志）</span><span style="font-family: KaiTi;color: #0070C0;letter-spacing: 0;font-size: 24px"><span style="font-family:KaiTi">》上发表研究论文：</span><a name="OLE_LINK1" href="http://blog.sciencenet.cn/undefined"></a></span><strong><span style="font-family: KaiTi;color: #0070C0;letter-spacing: 0;font-size: 24px">Efficacy of one-dose intramuscular rabies vaccine as pre-exposure prophylaxis in travellers</span></strong><span style="font-family: KaiTi;color: #0070C0;letter-spacing: 0;font-size: 24px">（</span><span style="font-family: KaiTi;color: #0070C0;letter-spacing: 0;font-size: 24px">一剂肌肉注射狂犬病疫苗作为旅行者暴露前预防措施的有效性</span><span style="font-family: KaiTi;color: #0070C0;letter-spacing: 0;font-size: 24px">）（见参考文献）。</span></h2><h2 style="margin: 15px 0px 23px; text-indent: 56px; padding: 0px; background: rgb(255, 255, 255); line-height: 2em;"><span style="font-family: KaiTi;color: #0070C0;letter-spacing: 0;font-size: 24px">该论文提供了狂犬病疫苗仅肌肉注射一针的免疫效果的宝贵</span><span style="font-family: KaiTi;color: #0070C0;letter-spacing: 0;font-size: 24px">资料。这将有助于我们全面理解狂犬病疫苗的免疫效果，从而可能进一步优化未来的狂犬病疫苗接种方案。</span></h2><p style="margin-top: 0;margin-right: 0;margin-bottom: 0;padding: 0;vertical-align: baseline;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="line-height: 200%;color: #2A2A2A;letter-spacing: 0;font-size: 24px">问题的提出：</span></strong></p><p style="margin-top:18px;margin-right:0;margin-bottom:18px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;vertical-align:baseline;line-height:200%"><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">目前的狂犬病</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">暴露前预防</span>(PrEP)</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">指南建议使用多剂量疫苗。</span></span></strong></p><p style="margin-top:18px;margin-right:0;margin-bottom:18px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;vertical-align:baseline;line-height:200%"><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">ＷＨＯ</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">预防性接种</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">原方案</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">：</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">IM （肌肉内）</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">第</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">0</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">、</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">7</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">、</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">21</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">(</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">或</span>28</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">天</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">)</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">，</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">3</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">针</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">共</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">3</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">次</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">，需时</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">共</span>3周或4周</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">。</span></span></strong></p><p style="margin-top:18px;margin-right:0;margin-bottom:18px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;vertical-align:baseline;line-height:200%"><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">ＷＨＯ</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">预防性接种</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">新方案</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">：</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 20px;background: #FFFFFF">IM </span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">（肌肉内）</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">第</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">0</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">、</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">7</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">天，</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">2</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">针</span>2次</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">，需时</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">共</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 20px;background: #FFFFFF">1</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">周</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #FF0000;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">。</span></span></strong></p><p style="margin-top:18px;margin-right:0;margin-bottom:18px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;vertical-align:baseline;line-height:200%"><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">旅行前</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">来诊所</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">咨询的旅行者有时没有足够的时间完成标准的预防计划。</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">如果</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">旅行者</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">只接种</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">1针疫苗，能在多大程度上得到免疫保护？</span></span></strong></p><p style="margin-top:18px;margin-right:0;margin-bottom:18px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;vertical-align:baseline;line-height:200%"><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">作者</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">通过</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">检测</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">抗体对模拟</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">暴露后预防</span>(PEP</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">)的反应，研究了一剂肌肉注射(IM)疫苗启动免疫系统</span></strong><strong><span style="text-decoration:underline;"><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">暴露前预防</span>(PrEP)</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">的有效性。</span></span></strong></p><p style="margin-top: 0;margin-right: 0;margin-bottom: 0;padding: 0;vertical-align: baseline;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="line-height: 200%;color: #2A2A2A;letter-spacing: 0;font-size: 24px">试验</span></strong><strong><span style="line-height: 200%;color: #2A2A2A;letter-spacing: 0;font-size: 24px"><span style="font-family:sans-serif">方法</span>:</span></strong></p><p style="margin-top:18px;margin-right:0;margin-bottom:18px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;vertical-align:baseline;line-height:200%"><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">此</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">项</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">与临床实践相结合的</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">临床试验在澳大利亚的一个专</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">业化的</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">旅行诊所进行</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">，涉及狂犬病暴露前和暴露后的干预措施</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">。</span></span></strong></p><p style="margin-top:18px;margin-right:0;margin-bottom:18px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;vertical-align:baseline;line-height:200%"><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">参与试验的</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">成人</span>(≥18岁)</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">都</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">没有狂犬病疫苗接种史。</span></span></strong></p><p style="margin-top:18px;margin-right:0;margin-bottom:18px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;vertical-align:baseline;line-height:200%"><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">在第</span>1次来访</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">时</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">，确认血清阴性，并给予</span>1剂0.5 mL IM</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">（肌肉注射）</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">狂犬病疫苗</span>(Verorab</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">，法国产品维尔博</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">)。在第2次访问(第1次访问后60天)，重复血清学检查，并于当天和3天后(第3次访问)再次给予</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">模拟的</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">PEP剂量(0.5 mL IM)</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">（参与者实际上未发生暴露）</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">。在第</span>4次访问(第2次访问后7天)重复血清学检查。</span></strong></p><p style="margin-top: 0;margin-right: 0;margin-bottom: 0;padding: 0;vertical-align: baseline;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="line-height: 200%;color: #2A2A2A;letter-spacing: 0;font-size: 24px"><span style="font-family:sans-serif">结果</span>:</span></strong></p><p style="margin-top:18px;margin-right:0;margin-bottom:18px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;vertical-align:baseline;line-height:200%"><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">共纳入</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">94名抗体阴性的参与者(<50年</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">岁的</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">50人，</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">≥ 50</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">岁的</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">44人</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">)。在第2次访问</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">时</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">，</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">参与者</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><50</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">岁</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">和</span> ≥ 50年</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">年龄组中</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">抗体阳性</span>(≥0.5 </span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">IU</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">/mL)</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">者所占比例分别为</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">38.0%和31.8%。在第4次访问时，所有参与者的抗体都呈阳性;</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">参与者</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><50</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">岁</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">和</span> ≥ 50年</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">年龄组中</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">抗体</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">水平</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"> > 4 </span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">IU</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">/mL</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">者所占比例分别为</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">82.0%和47.7%。</span></strong></p><p style="margin-top: 0;margin-right: 0;margin-bottom: 0;padding: 0;vertical-align: baseline;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="line-height: 200%;color: #2A2A2A;letter-spacing: 0;font-size: 24px"><span style="font-family:sans-serif">结论</span>:</span></strong></p><p style="margin-top:18px;margin-right:0;margin-bottom:18px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;vertical-align:baseline;line-height:200%"><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">一剂</span>IM疫苗作为PrEP对</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">这</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">两个年龄组的免疫系统都是有效的，导致在开始模拟</span>PEP后7天迅速产生抗体。</span></strong></p><p style="margin-top:18px;margin-right:0;margin-bottom:18px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;vertical-align:baseline;line-height:200%"><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">在开始旅行前</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">如果没有足够的时间完成标准的</span>PrEP计划，可以考虑将单剂注射作为短途旅行的替代计划，而不是根本不给旅行者提供任何剂量。</span></strong></p><p style="margin-top:18px;margin-right:0;margin-bottom:18px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;vertical-align:baseline;line-height:200%"><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">那些因各种原因只接种了</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">1针疫苗者在2个月（60天）后大约</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">1/3</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">的人仍有足够的免疫保护作用</span><span style="font-family:KaiTi">(</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">抗体</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">水平</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">≥0.5 </span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">IU</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">/mL)</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">。不同年龄组的人结果有差别，具体结果是：</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">参与者</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><50</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">岁年龄组</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">和</span> ≥ 50</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">岁年龄组中在第</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">60天</span><a name="OLE_LINK3" href="http://blog.sciencenet.cn/undefined"></a></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">抗体阳性</span>(≥0.5 </span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">IU</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">/mL)</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">者所占比例分别为</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">38.0%和31.8%。</span></strong></p><p style="margin-top:18px;margin-right:0;margin-bottom:18px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;vertical-align:baseline;line-height:200%"><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">接种了</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">1针疫苗后，在第60天时加强1针，63天时加强第2针，第70天时</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">所有参与者的抗体都呈阳性</span>(≥0.5 </span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">IU</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">/mL);</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">其中一部分人的抗体水平</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">> 4 </span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">IU</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">/mL</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">，有充分的保护作用。但高龄组的抗体水平能达到此数值的人数要少得多，具体结果是加强</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">2针后到</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">第</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">70天时</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">参与者</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">抗体</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">水平</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"> > 4 </span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">IU</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">/mL</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">者在</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><50</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">岁</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">和</span> ≥</span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">50</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:KaiTi">岁年龄组中所占比例分别为</span></span></strong><strong><span style="font-family: KaiTi;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px;background: #FFFFFF">82.0%和47.7%。</span></strong></p><p style="margin-top: 0;margin-right: 0;margin-bottom: 0;padding: 0;vertical-align: baseline;line-height: 200%;background: rgb(255, 255, 255)"><strong><span style="line-height: 200%;color: #2A2A2A;letter-spacing: 0;font-size: 24px">参考文献：</span></strong></p><p style="margin: 0px 25px 0px 0px; text-indent: 43px; padding: 0px; vertical-align: baseline; line-height: 200%; background: rgb(255, 255, 255);"><span style="font-family: Helvetica;line-height: 200%;letter-spacing: 0;font-size: 20px">Deborah J Mills</span><span style="font-family: SimSun;line-height: 200%;letter-spacing: 0;font-size: 20px"> </span><span style="font-family: Helvetica;line-height: 200%;letter-spacing: 0;font-size: 20px">et al.,</span><span style="font-family: Helvetica;line-height: 200%;color: #006FB7;letter-spacing: 0;font-size: 20px"> </span><strong><span style="font-family: serif;line-height: 200%;color: #2A2A2A;letter-spacing: 0;font-size: 20px">Efficacy of one-dose intramuscular rabies vaccine as pre-exposure prophylaxis in travellers</span></strong><span style=";font-family:Calibri;line-height:200%;font-size:20px">,</span><span style=";font-family:SimSun;line-height:200%;font-size:20px"> </span><strong><em><span style="font-family: Helvetica;line-height: 200%;color: #2A2A2A;letter-spacing: 0;font-size: 20px">Journal of Travel Medicine</span></em></strong><span style="font-family: Helvetica;line-height: 200%;color: #2A2A2A;letter-spacing: 0;font-size: 20px">,</span><span style="font-family: Helvetica;line-height: 200%;color: #2A2A2A;letter-spacing: 0;font-size: 20px"> 10 April 2</span><strong><span style="font-family: Helvetica;line-height: 200%;color: #2A2A2A;letter-spacing: 0;font-size: 20px">021</span></strong><strong><span style="font-family: Helvetica;line-height: 200%;color: #2A2A2A;letter-spacing: 0;font-size: 20px">，</span></strong><a href="https://doi.org/10.1093/jtm/taab059" target="_blank"><span style="font-family: Helvetica;line-height: 200%;color: #006FB7;letter-spacing: 0;font-size: 20px">https://doi.org/10.1093/jtm/taab059</span></a><span style="font-family: Helvetica;line-height: 200%;color: #006FB7;letter-spacing: 0;font-size: 20px">.</span></p>                    <br><br>
                                        <label style="font-size:13px; color:#850f0f">转载本文请联系原作者获取授权，同时请注明本文来自严家新科学网博客。<br>链接地址：</label><a href="http://blog.sciencenet.cn/blog-347754-1283929.html" target="_blank" style="font-size:13px; color:#850f0f">http://blog.sciencenet.cn/blog-347754-1283929.html </a>
  <br><br>上一篇：<a href="http://blog.sciencenet.cn/blog-347754-1283518.html" target="_black">新冠病毒在单个宿主内的多样性被低估</a><br>                    <!--大赛结束-->
                                        
  
</div>
            